We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Real-Life Study of Patient Preference for Dupilumab or Revision Surgery for Recurrent Chronic Rhinosinusitis with Nasal Polyps.
- Authors
Gangl, Katharina; Liu, David Tianxiang; Bartosik, Tina; Campion, Nicholas James; Vyskocil, Erich; Mueller, Christian Albert; Knerer, Birgit; Eckl-Dorna, Julia; Schneider, Sven
- Abstract
(1) Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) has a high rate of recurrence in patients, despite therapy with local corticosteroids and functional endoscopic sinus surgery. Dupilumab, a recombinant monoclonal human IgG4 antibody directed against the IL-4 receptor α that inhibits both IL-4 and IL-13 signal transduction, is available for symptomatic therapy. Patient preference between repeated surgery and injection therapy with Dupilumab is not known. (2) Methods: Patients who had experienced at least one surgical intervention for nasal polyps and were treated with Dupilumab for at least 3 months completed a retrospective patient questionnaire. (3) Results: In a cohort of 75 previously operated CRSwNP patients, 91.5% preferred therapy with Dupilumab to repeated surgery for nasal polyps. Preference for Dupilumab in the subgroups of patients with concomitant Non-steroidal Anti-inflammatory Drugs Exacerbated Respiratory Disease (N-ERD) (n = 32), patients with concomitant asthma (n = 25), and patients without concomitant disease (n = 18) was 100%, 96%, and 72%, respectively. (4) Conclusions: Patient preference for Dupilumab over repeat surgery is strongest in previously operated CRSwNP patients with concomitant asthma or N-ERD, but remains very high in patients without concomitant disease.
- Subjects
ENDOSCOPIC surgery; NASAL polyps; PATIENT preferences; REOPERATION; DUPILUMAB; SINUSITIS
- Publication
Journal of Personalized Medicine, 2024, Vol 14, Issue 4, p338
- ISSN
2075-4426
- Publication type
Article
- DOI
10.3390/jpm14040338